GC Cell Corporation (KOSDAQ:144510)
12,470
-570 (-4.37%)
Jul 21, 2026, 2:24 PM KST
GC Cell Market Cap
GC Cell has a market cap or net worth of 195.95 billion as of July 20, 2026. Its market cap has decreased by -37.00% in one year.
Market Cap
195.95B
Enterprise Value
296.60B
Revenue
163.35B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,470.00
ChartMarket Cap Chart
Since June 23, 2016, GC Cell's market cap has decreased from 507.65B to 195.95B, a decrease of -61.40%. That is a compound annual growth rate of -9.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 200.46B | -46.32% |
| Dec 30, 2025 | 373.42B | 4.85% |
| Dec 30, 2024 | 356.14B | -47.90% |
| Dec 28, 2023 | 683.53B | -3.46% |
| Dec 29, 2022 | 708.04B | -55.94% |
| Dec 30, 2021 | 1.61T | 65.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 289.66B |
| SillaJen | 277.80B |
| Proteina | 240.02B |
| BINEX | 208.92B |
| EASY BIO,Inc. | 208.09B |
| Anterogen.Co.,Ltd. | 183.21B |
| HLB Therapeutics | 171.62B |
| JETEMA, | 165.93B |